MoonJung Choi, Ph.D., is a Research Scientist at Brown University’s Department of Medicine within the Warren Alpert Medical School, specializing in cancer immunotherapy. He earned his Combined M.S./Ph.D. from Yonsei University’s Department of Biomedical Laboratory Science, focusing on the development of tumor-targeted nanoparticles for triple-negative breast cancer theranosis. With a cumulative GPA of 4.43/4.5, MoonJung’s academic journey was guided by Yong Serk Park. Prior to Brown University, he served as a Postdoctoral Fellow at the Korea Institute of Science and Technology, researching immune cancer therapy. MoonJung’s current research at Brown University includes genetic engineering of T cells and oncolytic adenovirus therapies for glioblastoma treatment. His expertise spans nanomedicine, gene therapy, and cancer immunotherapy, supported by a robust skill set in cell and molecular biology, histology, and animal experimentation. MoonJung Choi is dedicated to advancing novel therapies to combat cancer and improve patient outcomes.
Professional Profile:
Google Scholar
Education:
MoonJung Choi holds a Combined M.S./Ph.D. from Yonsei University’s Department of Biomedical Laboratory Science, where he specialized in the development of tumor-targeted nanoparticles for triple-negative breast cancer theranosis, achieving a cumulative GPA of 4.43/4.5. His academic pursuits were under the mentorship of Yong Serk Park. Previously, he served as a Postdoctoral Fellow at the Korea Institute of Science and Technology, focusing on immune cancer therapy.
Work Experience:
MoonJung Choi works as a Research Scientist at Brown University’s Department of Medicine within the Warren Alpert Medical School. His research focuses on cancer immunotherapy, specifically genetic engineering of T cells and oncolytic adenovirus therapies for glioblastoma treatment. His expertise spans nanomedicine, gene therapy, and cancer immunotherapy, complemented by extensive skills in cell and molecular biology, histology, and animal experimentation. MoonJung Choi is committed to advancing innovative therapies to combat cancer and enhance patient outcomes.
Publication Top Notes:
–